- Home
- SCHL vs EVMN Comparison
SCHL vs EVMN Comparison
Compare SCHL & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCHL | EVMN |
|---|---|---|
| Founded | 1920 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Books | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.4M | 825.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCHL | EVMN |
|---|---|---|
| Price | $39.63 | $22.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $40.00 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 545.2K | 288.0K |
| Earning Date | 03-19-2026 | 06-11-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $1,487,100,000.00 | N/A |
| Revenue This Year | $1.88 | N/A |
| Revenue Next Year | $4.05 | N/A |
| P/E Ratio | $20.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.78 | $13.89 |
| 52 Week High | $43.39 | $33.20 |
Technical Indicators
Market Signals| Indicator | SCHL | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 42.32 |
| Support Level | $37.97 | $21.39 |
| Resistance Level | $43.39 | $23.08 |
| Average True Range (ATR) | 1.23 | 1.56 |
| MACD | -0.20 | -0.20 |
| Stochastic Oscillator | 53.35 | 20.44 |
Price Performance
Historical ComparisonAbout SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.